文献速递神经肿瘤

脑肿瘤术后预防性左乙拉西坦用药时长:一项前瞻性随机试验

Duration of Prophylactic Levetiracetam After Surgery for Brain Tumor: A Prospective Randomized Trial.
PubMed 文献 · Neurosurgery · 2022-09-26

这项前瞻性随机试验将81例无癫痫史的幕上脑肿瘤切除患者随机分为预防性左乙拉西坦1周组(40例)和6周组(41例),主要结局为用药6周后神经毒性评分变化,次要结局为癫痫发生率。结果显示两组神经毒性及抑郁评分无显著差异,整个队列癫痫发生率低,每组各1例在随访期间发生癫痫。

要点

  • 预防性左乙拉西坦1周与6周在神经毒性和抑郁评分上无显著差异。
  • 整个队列癫痫发生率低,1周组和6周组各1例发生癫痫。
  • 左乙拉西坦用法:早期口服缓释片1000 mg,后期因药品短缺改为500 mg每日两次。

核心结论

  • 预防性左乙拉西坦使用1周或6周均未导致显著的神经毒性或抑郁。
  • 幕上脑肿瘤切除术后癫痫发生率低,与治疗时长无关。

研究设计与样本

  • 前瞻性随机试验,纳入无癫痫史的幕上脑肿瘤手术切除患者。
  • 术后48小时内随机分为预防性左乙拉西坦1周组(40例)或6周组(41例),共81例。
  • 主要结局为用药6周后神经毒性评分变化,次要结局为癫痫发生率。
  • 早期患者口服左乙拉西坦缓释片1000 mg,后期因药品短缺改为500 mg每日两次。

主要发现

  • 整个队列神经毒性评分从基线至再评估略有改善。
  • 1周组与6周组在神经毒性或抑郁评分上无显著差异。
  • 癫痫发生率低,1周组和6周组各1例在随访期间发生癫痫。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Levetiracetam is commonly used as a prophylactic antiseizure medication in patients undergoing surgical resection of brain tumors. OBJECTIVE: To quantitate side effects experienced in patients treated with 1 week vs 6 weeks of prophylactic levetiracetam using validated measures for neurotoxicity and depression. METHODS: Patients undergoing surgical resection of a supratentorial tumor with no seizure history were randomized within 48 hours of surgery to receive prophylactic levetiracetam for the duration of either 1 or 6 weeks. Patients were given oral levetiracetam extended release 1000 mg during the first part of this study. Owing to drug backorder, patients enrolled later in this study received levetiracetam 500 mg BID. The primary outcome was the change in the neurotoxicity score 6 weeks after drug initiation. The secondary outcome was seizure incidence. RESULTS: A total of 81 patients were enrolled and randomized to 1 week (40 patients) or 6 weeks (41 patients) of prophylactic levetiracetam treatment. The neurotoxicity score slightly improved in the overall cohort between baseline and reassessment. There was no significant difference between groups in neurotoxicity or depression scores. Seizure incidence was low in the entire cohort of patients with 1 patient in each arm experiencing a seizure during the follow-up period. CONCLUSION: The use of prophylactic levetiracetam did not result in significant neurotoxicity or depression when given for either 1 week or 6 weeks. The incidence of seizure after craniotomy for tumor resection is low regardless of duration of therapy.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Rahman M, Eisenschenk S, Melnick K, et al. Duration of Prophylactic Levetiracetam After Surgery for Brain Tumor: A Prospective Randomized Trial. Neurosurgery. 2022. PMID: 36156532. doi:10.1227/neu.0000000000002164

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。